Mohamed Elshafie, Abdulrahman Radi, M. Abdelmawla, Hussein El-Ansarey
{"title":"异维甲酸后的中央旁急性中黄斑病变","authors":"Mohamed Elshafie, Abdulrahman Radi, M. Abdelmawla, Hussein El-Ansarey","doi":"10.4103/erj.erj_2_23","DOIUrl":null,"url":null,"abstract":"Paracentral acute middle maculopathy (PAMM) can be caused by a variety of retinal, ocular, iatrogenic, and systemic factors. Patients with PAMM typically have a sudden onset of paracentral scotomata, difficulty focusing, and/or blurred central vision. Isotretinoin is associated with multiple ocular side effects, including eye dryness and loss of night vision. In this study, we present a case of PAMM after 13 months of isotretinoin treatment with no evidence of other causes or relevant medical history.","PeriodicalId":201997,"journal":{"name":"Egyptian Retina Journal","volume":"85 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2022-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"1","resultStr":"{\"title\":\"Paracentral acute middle maculopathy after isotretinoin\",\"authors\":\"Mohamed Elshafie, Abdulrahman Radi, M. Abdelmawla, Hussein El-Ansarey\",\"doi\":\"10.4103/erj.erj_2_23\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Paracentral acute middle maculopathy (PAMM) can be caused by a variety of retinal, ocular, iatrogenic, and systemic factors. Patients with PAMM typically have a sudden onset of paracentral scotomata, difficulty focusing, and/or blurred central vision. Isotretinoin is associated with multiple ocular side effects, including eye dryness and loss of night vision. In this study, we present a case of PAMM after 13 months of isotretinoin treatment with no evidence of other causes or relevant medical history.\",\"PeriodicalId\":201997,\"journal\":{\"name\":\"Egyptian Retina Journal\",\"volume\":\"85 1\",\"pages\":\"0\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2022-07-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"1\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Egyptian Retina Journal\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.4103/erj.erj_2_23\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Egyptian Retina Journal","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.4103/erj.erj_2_23","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
Paracentral acute middle maculopathy after isotretinoin
Paracentral acute middle maculopathy (PAMM) can be caused by a variety of retinal, ocular, iatrogenic, and systemic factors. Patients with PAMM typically have a sudden onset of paracentral scotomata, difficulty focusing, and/or blurred central vision. Isotretinoin is associated with multiple ocular side effects, including eye dryness and loss of night vision. In this study, we present a case of PAMM after 13 months of isotretinoin treatment with no evidence of other causes or relevant medical history.